NCT04526587View on ClinicalTrials.gov

Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors

RecruitingOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

July 3, 2020

Primary Completion Date

July 3, 2030

Study Completion Date

July 3, 2030

Conditions
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8
Interventions
OTHER

Cytology Specimen Collection Procedure

Undergo collection of blood, tissue, ascites or pleural effusions, and fresh body fluids or fresh biopsy samples

OTHER

Diagnostic Laboratory Biomarker Analysis

Correlative studies

OTHER

Medical Chart Review

Patient's electronic health records are reviewed

Trial Locations (1)

14263

RECRUITING

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER